Literature DB >> 29678335

Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy.

Davide Stolfo1, Nicole Ceschia2, Massimo Zecchin2, Antonio De Luca2, Marco Gobbo2, Giulia Barbati3, Marta Gigli2, Marco Masè2, Bruno Pinamonti2, Alberto Pivetta2, Marco Merlo2, Gianfranco Sinagra2.   

Abstract

Arrhythmic risk stratification in idiopathic dilated cardiomyopathy (IDC) remains a major concern. As the ventricles remodel in time, risk factors for arrhythmic death may change. A cohort of 710 patients with idiopathic dilated cardiomyopathy, without previous ventricular arrhythmias, was retrospectively studied to understand how risks vary in time. The primary end point was a composite of sudden cardiac death, ventricular fibrillation, sustained ventricular tachycardia, and appropriate implantable cardioverter-defibrillator interventions. The prediction of the arrhythmic outcome was assessed dynamically through landmark analysis. Patients were assessed at baseline, short term (12 months, interquartile range 6 to 18), and long-term (72 months, interquartile range 60 to 84). The strongest risk predictors at each evaluation were combined in 3 multivariate models. During a median follow-up of 102 months, 80 patients (11%) experienced the primary end point. At baseline, QRS duration (p = 0.008), disease duration (p <0.001), and mitral regurgitation (p = 0.010) were significantly associated with the primary end point. The 12 months' landmark model included disease duration (p = 0.049), syncope (p = 0.005), New York Heart Association classes III and IV (p = 0.02), and indexed left ventricular end-diastolic volume (p = 0.001). Finally, the 72 months' landmark model combined the indexed left ventricular end-diastolic volume (p = 0.048), the left ventricular ejection fraction (p = 0.008), and the left atrial area (p = 0.001). All the 3 models provided a satisfactory accuracy (area under the curve ranging from 0.76 to 0.82, p <0.001). With an implantable cardioverter-defibrillator, the natural course of the disease influences the effect of arrhythmic risk factors overtime. Different predictors should be considered for the risk stratification according to the timing of assessment. Impaired left ventricular ejection fraction was significantly associated with major arrhythmias only in the long term.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29678335     DOI: 10.1016/j.amjcard.2018.02.055

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Identification and Functional Characterization of an ISL1 Mutation Predisposing to Dilated Cardiomyopathy.

Authors:  Ying-Jia Xu; Zhang-Sheng Wang; Chen-Xi Yang; Ruo-Min Di; Qi Qiao; Xiu-Mei Li; Jia-Ning Gu; Xiao-Juan Guo; Yi-Qing Yang
Journal:  J Cardiovasc Transl Res       Date:  2018-12-10       Impact factor: 4.132

2.  Longitudinal Arrhythmic Risk Assessment Based on Ejection Fraction in Patients with Recent-Onset Nonischemic Dilated Cardiomyopathy.

Authors:  Giulia De Angelis; Marco Merlo; Giulia Barbati; Silvia Bertolo; Antonio De Luca; Federica Ramani; Luigi Adamo; Gianfranco Sinagra
Journal:  J Am Soc Echocardiogr       Date:  2022-03-31       Impact factor: 7.722

Review 3.  Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy.

Authors:  M Akhtar; P M Elliott
Journal:  Curr Cardiol Rep       Date:  2019-11-25       Impact factor: 2.931

Review 4.  The Role of AI in Characterizing the DCM Phenotype.

Authors:  Clint Asher; Esther Puyol-Antón; Maleeha Rizvi; Bram Ruijsink; Amedeo Chiribiri; Reza Razavi; Gerry Carr-White
Journal:  Front Cardiovasc Med       Date:  2021-12-21

5.  Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy.

Authors:  Marco Cittar; Alberto Cipriani; Marco Merlo; Giancarlo Vitrella; Marco Masè; Anna Carrer; Giulia Barbati; Manuel Belgrano; Lorenzo Pagnan; Manuel De Lazzari; Benedetta Giorgi; Maria A Cova; Sabino Iliceto; Cristina Basso; Davide Stolfo; Gianfranco Sinagra; Martina Perazzolo Marra
Journal:  Front Cardiovasc Med       Date:  2021-11-30

6.  Toward Better Risk Stratification for Implantable Cardioverter-Defibrillator Recipients: Implications of Explainable Machine Learning Models.

Authors:  Yu Deng; Sijing Cheng; Hao Huang; Xi Liu; Yu Yu; Min Gu; Chi Cai; Xuhua Chen; Hongxia Niu; Wei Hua
Journal:  J Cardiovasc Dev Dis       Date:  2022-09-17

Review 7.  CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.

Authors:  Laura Keil; Céleste Chevalier; Paulus Kirchhof; Stefan Blankenberg; Gunnar Lund; Kai Müllerleile; Christina Magnussen
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

8.  A Novel Gene Signature to Predict Survival Time and Incident Ventricular Arrhythmias in Patients with Dilated Cardiomyopathy.

Authors:  Chenliang Ge; Yan He
Journal:  Dis Markers       Date:  2020-09-15       Impact factor: 3.434

9.  Nomogram predicting death and heart transplantation before appropriate ICD shock in dilated cardiomyopathy.

Authors:  Yu Deng; Nixiao Zhang; Wei Hua; Sijing Cheng; Hongxia Niu; Xuhua Chen; Min Gu; Chi Cai; Xi Liu; Hao Huang; Minsi Cai; Shu Zhang
Journal:  ESC Heart Fail       Date:  2022-01-22

10.  Ventricular arrhythmias in patients with functional mitral regurgitation and implantable cardiac devices: implications of mitral valve repair with Mitraclip®.

Authors:  Tomás Benito-González; Xavier Freixa; Cosmo Godino; Maurizio Taramasso; Rodrigo Estévez-Loureiro; Daniel Hernandez-Vaquero; Ana Serrador; Luis Nombela-Franco; David Grande-Prada; Ignacio Cruz-González; Rodolfo San Antonio; Michele Galasso; Mara Gavazzoni; Carmen Garrote; Antonio Portolés-Hernández; Pablo Avanzas; Felipe Fernández-Vázquez; Isaac Pascual
Journal:  Ann Transl Med       Date:  2020-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.